Synlait Milk Ltd stock (NZSMLE0001S9): CEO exit puts spotlight on turnaround plan

New Zealand dairy processor Synlait Milk has announced the resignation of CEO Richard Wyeth after just one year in the role, adding fresh uncertainty around its ongoing turnaround and asset-sale plans.

New Zealand-based dairy processor Synlait Milk has confirmed that chief executive Richard Wyeth has resigned after roughly one year in the role, with the company appointing senior executive Leon Fung as acting CEO as of 14 May 2026, according to FoodBev as of 05/15/2026 and industry coverage from Dairy Industries International as of 05/14/2026.

Wyeth, who joined Synlait Milk in 2025, will remain with the company until 30 June 2026 to support an orderly transition, while the board evaluates its longer-term plans for the chief executive role, according to New Zealand business outlet BusinessDesk as of 05/15/2026.

As of: 05/15/2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Synlait Milk Limited
• Sector/industry: Dairy processing, food ingredients
• Headquarters/country: Dunsandel, New Zealand
• Core markets: New Zealand, China, Asia-Pacific, with exports that can reach US and other markets
• Key revenue drivers: Infant formula ingredients, nutritional powders, liquid milk and cream products, contract manufacturing
• Home exchange/listing venue: New Zealand Exchange (ticker: SML), also listed on ASX
• Trading currency: New Zealand dollar (NZD)

Synlait Milk Ltd: core business model

Synlait Milk is a New Zealand dairy processor focused on producing value-added milk products such as infant formula base powders, nutritional ingredients and specialty dairy products. The company operates large-scale processing facilities that source raw milk from contracted dairy farms and convert it into high-specification ingredients for branded customers and global food companies.

The company’s strategy over the past decade has been to move up the value chain from commodity milk powders into higher-margin categories, particularly infant nutrition and advanced nutrition ingredients. Synlait Milk has supplied ingredients for infant formula brands sold into China and other Asian markets, positioning itself as a specialist manufacturing partner rather than a consumer-facing brand in its own right.

In the New Zealand dairy sector, Synlait Milk competes with larger co-operative processors but differentiates itself through tailored contracts, specialty processing capabilities and quality assurance programs that support premium products. Its customer base has historically included multinational food groups and regionally focused nutrition brands that rely on Synlait’s manufacturing scale and regulatory expertise.

For international investors, including those in the United States, Synlait Milk represents exposure to global demand for infant formula and dairy-based nutrition products, as well as to agricultural export flows from New Zealand. The company’s fortunes are closely linked to trade conditions, consumer demand in China and Asia, and the relative strength of dairy commodity and ingredient markets.

Main revenue and product drivers for Synlait Milk Ltd

Synlait Milk’s largest revenue contributor is its advanced nutrition and infant formula ingredients segment, where it manufactures base powders and finished products on contract for brand owners. These contracts can be multi-year in nature and require stringent quality controls and certification, particularly for Chinese and other regulated markets. This segment typically offers higher margins than basic commodity milk powder.

The company also generates revenue from bulk dairy ingredients such as skim milk powder, whole milk powder, anhydrous milk fat and cream products. These are sold into food manufacturing, beverage and foodservice channels in multiple export markets. While these products are more exposed to global dairy price cycles, they provide important volume utilization for Synlait’s processing plants.

In addition, Synlait Milk has developed liquid milk and cream capabilities, supplying private-label and branded products to retail and foodservice customers in New Zealand and potentially in selected export markets. This diversification aims to smooth earnings and reduce dependency on a narrow set of infant formula contracts.

The company’s half-year results for the six months ended 31 January 2026 showed revenue of about US$550 million (NZ$949 million), but Synlait reported an EBITDA loss for the period, highlighting ongoing profitability challenges during its turnaround, according to sector coverage cited by Dairy Business MEA as of 05/15/2026. Management has outlined asset sales and cost reductions as part of a plan to stabilize the balance sheet and return the business to sustainable earnings.

Synlait has previously detailed a roadmap that includes selling certain North Island assets and prioritizing core operations at its main processing sites, according to a company presentation lodged with the Australian Securities Exchange in 2025. That roadmap is intended to reduce debt, streamline operations and focus on contracts and product lines that can deliver higher returns, although execution risk remains elevated.

Industry trends and competitive position

The global dairy industry has experienced shifting demand patterns over recent years, with slower growth in some traditional fluid milk markets but continued interest in high-value categories such as infant nutrition, medical nutrition and specialty ingredients. For processors like Synlait Milk, success increasingly depends on securing long-term contracts in these premium segments rather than relying on volatile commodity exports.

New Zealand remains one of the world’s largest dairy exporters, and companies based there benefit from access to pasture-based milk supply and established trade links with China and other Asian markets. However, competition is intense, including from domestic co-operatives and international players, and regulatory requirements in markets such as China can change, affecting import conditions for infant formula and related products.

Synlait Milk’s competitive position has been shaped by its ability to meet strict quality and traceability requirements and by its investment in modern processing assets. At the same time, financial pressures and changes in customer relationships have weighed on its performance in recent years, contributing to the need for a restructuring roadmap and raising questions about how the company will position itself among global dairy ingredient suppliers.

Why Synlait Milk Ltd matters for US investors

For US investors looking beyond domestic markets, Synlait Milk offers exposure to New Zealand’s dairy export sector and to global demand for infant formula and nutritional ingredients, which are influenced by demographics and income levels in Asia and other regions. This exposure can provide diversification benefits relative to US-based food and agriculture stocks, which may be more tied to North American consumption patterns.

Synlait shares trade in New Zealand dollars on the NZX and are also listed on the ASX, which means US investors typically access the stock via international brokerage platforms. Currency movements between the US dollar and New Zealand dollar can affect returns for US-based holders, adding a foreign exchange dimension on top of the company’s operational performance.

In addition, developments at Synlait can be relevant for US investors interested in global supply chains for infant formula and dairy ingredients. Events such as changes in leadership, shifts in customer contracts or regulatory developments in key markets may indirectly influence pricing and supply dynamics in categories where US manufacturers and retailers operate.

Conclusion

The unexpected resignation of CEO Richard Wyeth after only a year, alongside the appointment of Leon Fung as acting chief executive, adds a further layer of uncertainty to Synlait Milk’s already demanding turnaround. Recent half-year figures underscore that the company is still working through profitability and balance sheet challenges, even as it pushes ahead with asset sales and a more focused strategy.

For US and other international investors, Synlait represents a concentrated bet on New Zealand’s role in the global dairy supply chain and on demand for infant formula and advanced nutrition products, particularly in Asia. Leadership stability, execution of the restructuring roadmap and the evolution of key customer relationships are likely to be central themes for the stock in the coming quarters, and they will help determine whether Synlait can translate its processing capabilities into more consistent financial outcomes over time.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.